Phase 3 TROPiCS-02 Study Met the Primary Endpoint of Progression-Free Survival in Late-Line HR+/HER2- Metastatic Breast CancerBusiness Wire • 03/07/22
Goldman Sachs Says Buy High-Dividend Stocks That Help Counter Inflation: 6 Top Picks24/7 Wall Street • 03/04/22
Gilead (GILD) Down 7% Since Last Earnings Report: Can It Rebound?Zacks Investment Research • 03/03/22
Gilead gets a complete response letter from FDA about the vial used to store an experimental HIV drugMarket Watch • 03/01/22
Gilead Receives Complete Response Letter From U.S. FDA for Investigational Lenacapavir Due to Vial Compatability IssuesBusiness Wire • 03/01/22
New Clinical Data Support the Sustained Efficacy of Long-acting Lenacapavir, Gilead's Investigational HIV-1 Capsid InhibitorBusiness Wire • 02/16/22
Phase 2/3 Interim Data Evaluating the Safety, Tolerability and Clinical Outcomes of Veklury® (Remdesivir) in Pediatric Patients With COVID-19 Presented at CROI 2022Business Wire • 02/11/22
Biktarvy® Demonstrates High Efficacy and Durable Viral Suppression at Five Years, in Treatment-Naïve AdultsBusiness Wire • 02/11/22
Gilead's Remdesivir Retains Antiviral Activity Against Several COVID-19 Variants, Including OmicronBenzinga • 02/11/22
Gilead says in-vitro study shows its COVID-19 drug Veklury is active against omicronMarket Watch • 02/11/22